Abstract
A novel affinity peptide S1 (LIDHEWKENYFPLSF) was screened out via a "one bead one compound" (OBOC) approach on a microarray device. It was identified that S1 could specifically recognize and bind to vascular endothelial growth factor receptor 2 (VEGFR2), which is an angiogenesis biomarker. Moreover, S1-functionalized liposomes (S1-LS) could achieve efficient nanoscale drug delivery under the conditions of VEGFR2-overexpression in vitro and in vivo. It was demonstrated that S1-LS would be a promising VEGFR2-targeting drug delivery system.
Original language | English |
---|---|
Pages (from-to) | 7087-7091 |
Number of pages | 5 |
Journal | Journal of Materials Chemistry B |
Volume | 4 |
Issue number | 44 |
DOIs | |
Publication status | Published - 2016 |
Externally published | Yes |
Fingerprint
Dive into the research topics of 'Peptide functionalized targeting liposomes: For nanoscale drug delivery towards angiogenesis'. Together they form a unique fingerprint.Cite this
Han, Q., Jia, X., Qian, Y., Wang, Z., Yang, S., Jia, Y., Wang, W., & Hu, Z. (2016). Peptide functionalized targeting liposomes: For nanoscale drug delivery towards angiogenesis. Journal of Materials Chemistry B, 4(44), 7087-7091. https://doi.org/10.1039/c6tb01823h